Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Breakthrough therapy drugs are intended to treat serious and life-threatening conditions. The breakthrough therapy is the designation given by FDA for the drugs when there is a preliminary clinical evidence indicates that the drug proves a substantial improvement over available drug treatment.
Breakthrough therapy designation requires additional planning for the pricing, market access and reimbursements acts as restraints in the growth of the market. Uncertainty around the breakthrough therapy drugs acts as a primary challenge for the manufacturers.
The report details the trend, potential and market size of Breakthrough Therapy Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Breakthrough Therapy Drugsmarket, defines the market attractiveness level of Breakthrough Therapy Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Breakthrough Therapy Drugs industry, describes the types of Breakthrough Therapy Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Breakthrough Therapy Drugs market and the development prospects and opportunities of Breakthrough Therapy Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Breakthrough Therapy Drugs market in Chapter 13.
By Player:
Merck
Genentech
Vertex Pharmaceuticals Incorporated
Gilead
Pfizer
AbbVie
Bristol-Myers Squibb Company
Novartis
By Type:
Oncology
Anti-Viral
Neurology
Others
By End-User:
Hospitals
Clinics
Ambulatory Services
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Breakthrough Therapy Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Breakthrough Therapy Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Breakthrough Therapy Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Breakthrough Therapy Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Breakthrough Therapy Drugs Market Analysis and Outlook to 2022
-
7.1 Global Breakthrough Therapy Drugs Consumption (2017-2022)
-
7.2 United States Breakthrough Therapy Drugs Consumption (2017-2022)
-
7.3 Europe Breakthrough Therapy Drugs Consumption (2017-2022)
-
7.4 China Breakthrough Therapy Drugs Consumption (2017-2022)
-
7.5 Japan Breakthrough Therapy Drugs Consumption (2017-2022)
-
7.6 India Breakthrough Therapy Drugs Consumption (2017-2022)
-
7.7 South Korea Breakthrough Therapy Drugs Consumption (2017-2022)
8 Region and Country-wise Breakthrough Therapy Drugs Market Analysis and Outlook to 2028
-
8.1 Global Breakthrough Therapy Drugs Consumption Forecast (2022-2028)
-
8.2 United States Breakthrough Therapy Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Breakthrough Therapy Drugs Consumption Forecast (2022-2028)
-
8.4 China Breakthrough Therapy Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Breakthrough Therapy Drugs Consumption Forecast (2022-2028)
-
8.6 India Breakthrough Therapy Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Breakthrough Therapy Drugs Consumption Forecast (2022-2028)
9 Global Breakthrough Therapy Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Breakthrough Therapy Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Anti-Viral Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Neurology Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Breakthrough Therapy Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ambulatory Services Consumption and Growth Rate (2017-2022)
10 Global Breakthrough Therapy Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Breakthrough Therapy Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Anti-Viral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Neurology Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Breakthrough Therapy Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Ambulatory Services Consumption Forecast and Growth Rate (2022-2028)
11 Global Breakthrough Therapy Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Breakthrough Therapy Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Breakthrough Therapy Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Breakthrough Therapy Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Breakthrough Therapy Drugs Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Breakthrough Therapy Drugs Product and Service
-
14.2 Genentech
-
14.2.1 Genentech Company Details
-
14.2.2 Genentech Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Genentech Breakthrough Therapy Drugs Product and Service
-
14.3 Vertex Pharmaceuticals Incorporated
-
14.3.1 Vertex Pharmaceuticals Incorporated Company Details
-
14.3.2 Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Product and Service
-
14.4 Gilead
-
14.4.1 Gilead Company Details
-
14.4.2 Gilead Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Gilead Breakthrough Therapy Drugs Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Breakthrough Therapy Drugs Product and Service
-
14.6 AbbVie
-
14.6.1 AbbVie Company Details
-
14.6.2 AbbVie Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AbbVie Breakthrough Therapy Drugs Product and Service
-
14.7 Bristol-Myers Squibb Company
-
14.7.1 Bristol-Myers Squibb Company Company Details
-
14.7.2 Bristol-Myers Squibb Company Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb Company Breakthrough Therapy Drugs Product and Service
-
14.8 Novartis
-
14.8.1 Novartis Company Details
-
14.8.2 Novartis Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novartis Breakthrough Therapy Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Breakthrough Therapy Drugs
-
Figure Breakthrough Therapy Drugs Picture
-
Table Global Breakthrough Therapy Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Breakthrough Therapy Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Breakthrough Therapy Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Breakthrough Therapy Drugs Consumption by Country (2017-2022)
-
Figure United States Breakthrough Therapy Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Breakthrough Therapy Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Breakthrough Therapy Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Breakthrough Therapy Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Breakthrough Therapy Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Breakthrough Therapy Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Breakthrough Therapy Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Breakthrough Therapy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Breakthrough Therapy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Breakthrough Therapy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Breakthrough Therapy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Breakthrough Therapy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Breakthrough Therapy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Viral Consumption and Growth Rate (2017-2022)
-
Figure Global Neurology Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Services Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-Viral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Services Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Breakthrough Therapy Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Breakthrough Therapy Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Breakthrough Therapy Drugs Product and Service
-
Table Genentech (Foundation Year, Company Profile and etc.)
-
Table Genentech Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Breakthrough Therapy Drugs Product and Service
-
Table Vertex Pharmaceuticals Incorporated (Foundation Year, Company Profile and etc.)
-
Table Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Product and Service
-
Table Gilead (Foundation Year, Company Profile and etc.)
-
Table Gilead Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Breakthrough Therapy Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Breakthrough Therapy Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Breakthrough Therapy Drugs Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Breakthrough Therapy Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Breakthrough Therapy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Breakthrough Therapy Drugs Product and Service
-
